However, the expression of ARs in these AR-negative prostate cancer cells reduces the expression of integrin αvβ6, thereby leading to decreased cell interactions with the substrate and impaired migration ability (refers to integrin αvβ6 in Table 1) [29]. The gene discussed is AR; the disease is prostate carcinoma.